Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Arginine/lysine polypeptide microcapsule inclusion as well as preparation method and application thereof

A technology of arginine and lysine, which is applied in the field of arginine/lysine polypeptide microcapsule inclusions and its preparation, can solve the problems of organic solvent residues, structural changes, expensive equipment, etc. release effect

Active Publication Date: 2022-04-29
GUANGDONG MARUBI BIOLOGICAL TECH CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the preparation of microcapsules by spray drying has certain requirements on temperature, which will cause structural changes in some heat-sensitive drugs, so this will restrict the application range of spray drying.
Although the preparation of microcapsules by the supercritical fluid method is environmentally friendly and can avoid the use of organic solvents, the equipment is expensive, and the parameter control and structural modification technology is not yet mature, so it is difficult to achieve industrialized mass production
Although the preparation of microcapsules by solvent diffusion method is simple and easy to empty, there is a problem of organic solvent residue

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Arginine/lysine polypeptide microcapsule inclusion as well as preparation method and application thereof
  • Arginine/lysine polypeptide microcapsule inclusion as well as preparation method and application thereof
  • Arginine/lysine polypeptide microcapsule inclusion as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] An arginine / lysine polypeptide microcapsule inclusion, comprising the following raw materials in parts by weight:

[0034] 0.002% compounded arginine / lysine polypeptide, 10% glycerin, 0.1% polyglyceryl-10 diisostearate, 0.1% polyglyceryl-10 laurate and 0.0001% dextran, remaining The amount is water; wherein, the compound arginine / lysine polypeptide is polypeptide A and polypeptide B with a mass ratio of 3:1, and the polypeptide A is red scorpion toxin, purchased from Zhejiang Paitide Biological Co., Ltd., model ZPC -019S; the polypeptide B is a conotoxin peptide, purchased from Zhejiang Paidetide Biological Co., Ltd., model ZPC-018S.

[0035] The preparation method of the above-mentioned arginine / lysine polypeptide microcapsule inclusions comprises the following steps:

[0036] 1) Fully stir and dissolve the compounded arginine / lysine polypeptide, polyglyceryl-10 diisostearate, polyglyceryl-10 laurate, glycerin, and dextran to obtain a uniform mixed solution.

[0037]...

Embodiment 2

[0039] An arginine / lysine polypeptide microcapsule inclusion, comprising the following raw materials in parts by weight:

[0040]0.005% compounded arginine / lysine polypeptide, 30% glycerin, 1% polyglyceryl-10 diisostearate, 0.5% polyglyceryl-10 laurate and 0.1% dextran, the remainder The amount is water; wherein, the compound arginine / lysine polypeptide is polypeptide A and polypeptide B with a mass ratio of 9:1, and the polypeptide A is red scorpion toxin, which is purchased from Zhejiang Paitide Biological Co., Ltd., and the model is ZPC -019S; the polypeptide B is a conotoxin peptide, purchased from Zhejiang Paidetide Biological Co., Ltd., model ZPC-018S.

[0041] The preparation method of the above-mentioned arginine / lysine polypeptide microcapsule inclusions comprises the following steps:

[0042] 1) Fully stir and dissolve the compounded arginine / lysine polypeptide, polyglyceryl-10 diisostearate, polyglyceryl-10 laurate, glycerin, and dextran to obtain a uniform mixed s...

Embodiment 3

[0045] An arginine / lysine polypeptide microcapsule inclusion, comprising the following raw materials in parts by weight:

[0046] 0.01% compounded arginine / lysine polypeptide, 20% glycerin, 0.5% polyglyceryl-10 diisostearate, 0.2% polyglyceryl-10 laurate and 0.005% dextran, the remainder The amount is water; wherein, the compound arginine / lysine polypeptide is polypeptide A and polypeptide B with a mass ratio of 5:1, and the polypeptide A is red scorpion toxin, purchased from Zhejiang Paitide Biological Co., Ltd., the model is ZPC -019S; the polypeptide B is a conotoxin peptide, purchased from Zhejiang Paidetide Biological Co., Ltd., model ZPC-018S.

[0047] The preparation method of the above-mentioned arginine / lysine polypeptide microcapsule inclusions comprises the following steps:

[0048] 1) Fully stir and dissolve the compounded arginine / lysine polypeptide, polyglyceryl-10 diisostearate, polyglyceryl-10 laurate, glycerin, and dextran to obtain a uniform mixed solution. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an arginine / lysine polypeptide microcapsule inclusion as well as a preparation method and application thereof. The microcapsule inclusion is prepared from the following raw materials: compound arginine / lysine polypeptide, glycerol, a polyglyceryl nonionic surfactant, glucan and the balance of water, wherein the compound arginine / lysine polypeptide comprises red scorpion toxin and conotoxin peptide. According to the microcapsule inclusion, a polyglyceryl nonionic surfactant is adopted as a carrier material, so that the compound polypeptide can be spontaneously wrapped in a microcapsule bilayer, a high-stability microcapsule inclusion structure is formed, and the compound polypeptide can achieve the effects of resisting aging, wrinkles and oxidation. The preparation method of the microcapsule inclusion avoids the addition of excipients and plasticizers required by traditional liposome preparation, and is simple. The microcapsule inclusion can be conveniently and stably dispersed in different types of cosmetic substrates such as skin care emulsion, cream, face cleansing, essence, toning lotion and the like to be prepared into cosmetics or skin care products for application.

Description

technical field [0001] The invention relates to the technical field of microcapsule inclusions, in particular to an arginine / lysine polypeptide microcapsule inclusion and its preparation method and application. Background technique [0002] Microcapsule technology refers to the technology of using natural or synthetic polymer materials to wrap dispersed solid particles, liquid or gas substances to form a semi-permeable or sealed microparticle technology. The process of encapsulation is called microencapsulation, and the tiny particles formed are called microcapsules. Microcapsules have two basic components, the substance enclosed in the microcapsule is called the core material, and the outer "shell" is called the wall material. During the preparation of microcapsules, the wall material can isolate the core material from the external environment, and then release the core material under appropriate conditions. [0003] Traditional techniques for preparing microcapsules incl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K8/14A61K8/34A61K8/64A61K8/73A61K8/86A61Q19/00
CPCA61K8/64A61K8/86A61K8/73A61K8/345A61K8/14A61Q19/00A61K2800/56A61K2800/805A61K2800/82
Inventor 孙云起郭朝万魏瑞敬聂艳峰胡露王娟
Owner GUANGDONG MARUBI BIOLOGICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products